PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival

por Batsios, Georgios, Viswanath, Pavithra, Subramani, Elavarasan, Najac, Chloe, Gillespie, Anne Marie, Santos, Romelyn Delos, Molloy, Abigail R., Pieper, Russell O., Ronen, Sabrina M.
Publicado 2019

MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma

por Molloy, Abigail R, Najac, Chloé, Viswanath, Pavithra, Lakhani, Aliya, Subramani, Elavarasan, Batsios, Georgios, Radoul, Marina, Gillespie, Anne Marie, Pieper, Russell O, Ronen, Sabrina M
Publicado 2020